Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network

Anthony M Boutelle1, Aicha R Mabene1, David Yao2

  • 1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.

PubMed

Insights

The tumor suppressor gene TP53 activates Zmat3 and Cdkn1a, which are crucial for preventing cancer by regulating cell division and migration. These genes are key players in the p53-mediated tumor suppression pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The tumor suppressor gene TP53 is frequently mutated in human cancers.
  • The specific p53 target genes critical for tumor suppression are not fully understood.
  • Zmat3, a p53-inducible gene, has emerged as a potential key effector in tumor suppression.

Purpose of the Study:

  • To investigate the role of Zmat3 in p53-mediated tumor suppression.
  • To identify cooperating p53-inducible genes in tumor suppression.
  • To elucidate the mechanism by which Zmat3 and its partners suppress tumors.

Main Methods:

  • Somatic genome editing (Tuba-seqUltra) and tumor barcoding in a mouse lung adenocarcinoma model.
  • Combinatorial in vivo CRISPR/Cas9 screens.
  • Meta-analyses of gene expression and Cancer Dependency Map data, alongside integrative RNA-sequencing and proteomic analyses.

Main Results:

  • Zmat3 was confirmed as a core component of p53-mediated tumor suppression.
  • Cdkn1a was identified as the most potent cooperating p53-induced gene in tumor suppression.
  • Combined Zmat3-Cdkn1a inactivation significantly enhanced cell proliferation and migration, mimicking p53 inactivation.

Conclusions:

  • ZMAT3 and CDKN1A function as critical effectors of p53-mediated tumor suppression across diverse contexts.
  • These genes regulate fundamental processes including cell division, migration, and extracellular matrix organization.
  • ZMAT3 and CDKN1A represent key nodes in a p53-induced gene network that actively opposes tumorigenesis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.6K